Michael Wacker Ph.D

Michael Wacker Ph.D General Information

Biography

Dr. Michael Wacker serves as General Partner at BioMedPartners. He co-founded and serves as Board Member at LimmaTech Biologics. He serves as Board Member at TOLREMO Therapeutics. He serves as Supervisory Board Member at Topas Therapeutics. He serves as Board Member at Scenic Biotech. He served as Chief Business Officer and Board Member at Polyneuron Pharmaceuticals. He serves as Board Member at Tubulis. He served as Chairman at Inositec. He brings more than fifteen years of experience in the life science industry to Polyneuron. Previously founded and was a Board Member of GlycoVaxyn, where he also served as CSO. GlycoVaxyn is a vaccine development company that was acquired by GSK in 2015 and valued the company at $212 million. He co-founded GlycoVaxyn in 2004 as a Spin-off company from the Swiss Federal Institute of Technology Zurich (ETHZ). He holds an M.Sc. in biochemistry and completed his Ph.D. and post-doctoral fellowship in microbiology at ETHZ. He is a Co-Founder and Board Member of Limmatech Biologics and Inura Medical. He is the author of several publications in international scientific journals, including Science and PNAS, as well as the inventor of various patent applications. He served as Board Member at Tubulis.